Innovations In Cancer Imaging And Targeted Radiotherapy To Improve Human Health
Funder
National Health and Medical Research Council
Funding Amount
$926,980.00
Summary
Through a process of discovery, development and investigation we will create medical devices and methods to improve cancer imaging and targeted radiotherapy. Successful completion of this program will directly impact on the treatment and lives of Australian cancer patients in the foreseeable future.This program will substantially build research capacity and productivity within Australia, raise Australia’s profile in cancer research and foster international collaboration.
Development Of Ultrahigh Resolution Brain Imaging For Investigating Neurological And Neurodegenerative Diseases
Funder
National Health and Medical Research Council
Funding Amount
$880,454.00
Summary
Understanding the structural and functional organisation of the human brain is the focus of enormous research effort. Neuroimaging is an extraordinarily important basic and clinical neuroscience discipline, and is unique in being able to provide direct in vivo measurements of the human brain, and crucially in individuals with brain and mind diseases. This research project will develop and utilise ultra-high resolution brain scanning to understand the mechanisms of neurodegenerative diseases.
Maps, Models And Modifiers Of Brain Changes In Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$715,210.00
Summary
Psychosis fundamentally alters one’s relationship with reality. Brain scans can map which parts of the brain are affected by psychosis, but they cannot identify the cellular processes that cause these changes. My fellowship aims to address this gap by integrating brain imaging with genetics and mathematical modelling to identify the brain circuits and molecules that impact risk for psychosis, and to develop targeted therapies to modify these dysfunctional circuits.
Developing Innovative Pathways For The Prevention Of Lifelong Cardiovascular Risk
Funder
National Health and Medical Research Council
Funding Amount
$753,300.00
Summary
My research aims to develop better ways to predict the risk of heart disease, better approaches to disease prevention and treatment and to ultimately develop more effective approaches to implementing these strategies into health care delivery.
Psychiatric disorders are associated with considerable social and economic burden which could be reduced if we understood mental health outcomes in high risk populations. This fellowship will use advanced brain imaging to understand the development of mental health disorders in those at high risk of bipolar disorder and dementia.
Defining Targets And Establishing Methods For Prevention, Diagnosis And Therapy Of Inflammation, Atherosclerosis And Thrombosis
Funder
National Health and Medical Research Council
Funding Amount
$847,490.00
Summary
My research focuses on preventing and treating atherosclerotic disease and its complications such as heart attack and stroke. This will be achieved by developing new imaging technologies, with the aim to detect unstable atherosclerotic plaques, as well as innovative new drugs preventing inflammation and thrombosis as the major contributors of heart attack and stroke.
Prof Alan Connelly is an internationally recognised neuroimaging researcher specialising in MRI. His major areas of research are in the development of new methods to acquire and process MR images of both structural and functional aspects of the brain, and the application of these novel methods to clinical neuroscience problems. His work has had a major impact in the field of epilepsy, where techniques that he pioneered have been widely adopted in specialist epilepsy centres worldwide.
We will apply genome-wide approaches to identify the gene networks that regulate the self-renewal and the differentiation of muscle stem cells and their fusion to muscle fibres. These studies will deliver the first characterisation of the molecules and pathways implicated in these processes, which are essential steps of muscle growth.
Cancer remains a significant clinical problem and causes considerable morbidity and mortality in society. Prof Maria Kavallaris is an international leader in cancer biology, therapy and the development of less toxic therapies for cancer using nanotechnology. Her vision is to build a leading program of applied research to develop treatments for aggressive disease that will reduce the impact and improve the outcomes for cancer patients.